Peri-Implant Soft Tissue and Health (PSTH)
27. april 2026 opdateret af: Tuğba ŞAHİN
Peri-Implant Soft Tissue and Peri-Implant Health
Implant patients who applied to Bolu Abant İzzet Baysal University provided anamnesis.
The study included 165 people with 272 implants.
The study includes implants that satisfied the inclusion criteria.
Plaque index (PI) [13], gingival index (GI) [14], bleeding on probing (BOP) [15], periodontal pocket depth (PPD), clinical attachment level (CAL), gingival recession (GR), GP, GT, and KTW were all assessed in every implant patient.
The presence of peri-implant mucositis or peri-implant health was assessed using the collected indices and radiographs.
The patients were split into two groups: those with peri-implant mucositis (136 implants) and those with peri-implant health (136 implants).
We investigated the relationships between each parameter and periodontal health.
Studieoversigt
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
272
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Turkey
-
Bolu, Turkey, Tyrkiet (Türkiye), 14300
- Bolu Abant Izzet Baysal University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Patients who have received implants
Beskrivelse
Inclusion Criteria:
- Patients aged 18-65 years who were systemically healthy, had a controlled medical conditions, and had fixed prostheses on the implants for at least 1 year following functional prosthetic loading of the dental implants.
Exclusion Criteria:
- Individuals with bruxism; those who smoke, were pregnant, or were breastfeeding; those who used anti-inflammatory drugs, immunosuppressants, or medications affecting the mucosa and bone; those who had undergone peri-implant disease treatment after implant placement; and those with residual cement residue and peri-implantitis related to prosthesis design or incorrectly placed implants.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Peri-implant mucositis
In the absence of bone loss, peri-implant mucositis refers to inflammation of the mucosa surrounding endosseous tissue
|
The classification of peri-implant diseases is based on clinical and radiographic criteria, distinguishing between peri-implant mucositis and peri-implantitis according to the presence of inflammation and bone loss.
|
|
Periodontal health
Peri-implant health is characterized by the absence of erythema, bleeding on probing, swelling, and suppuration, and is synonymous with implant success
|
The classification of peri-implant diseases is based on clinical and radiographic criteria, distinguishing between peri-implant mucositis and peri-implantitis according to the presence of inflammation and bone loss.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Gingival phenotype
Tidsramme: Baseline
|
If the probe was visible when placed in the sulcus, gingiva was classified as thin (≤1 mm), and if the reflection of the probe was not visible, it was classified as thick (> 1 mm).
|
Baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Gingival recession
Tidsramme: Baseline
|
Gingival recession er den målte afstand mellem emalje-cementgrænsen og den gingivale margin.
Vurderingen blev udført ved hjælp af en Williams parodontalprobe.
|
Baseline
|
|
Periodontal pocket depth
Tidsramme: Baseline
|
The periodontal pocket depth is the measurement of the distance between the gingival margin and the most coronal region of the junctional epithelium.
|
Baseline
|
|
Bleeding on probing
Tidsramme: Baseline
|
The bleeding on probing index was established as the occurrence of bleeding in the sulcus, thirty seconds after measuring the depth of the periodontal pockets in all dental implant.
|
Baseline
|
|
Plaque index
Tidsramme: Baseline
|
An index for estimating the status of oral hygiene by measuring dental plaque that occurs in the areas adjacent to the gingival margin.
0 is minimum and 3 is maximum.
The situation worsens as the score increases.
|
Baseline
|
|
Gingival index
Tidsramme: Baseline
|
The Gingival Index (GI) scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding.
0 is minimum and 3 is maximum.
|
Baseline
|
|
Clinical attachment level
Tidsramme: Baseline
|
The peri-implant clinical attachment level is determined by measuring the distance from the implant margin to the base of the mucosal sulcus using a Williams periodontal probe.
|
Baseline
|
|
Gingival thickness
Tidsramme: Baseline
|
GT was measured by inserting a number eight canal file from the buccal side of the implant until it reached the alveolar bone and then securing it with a stopper to determine the distance.
|
Baseline
|
|
Keratinized tissue width
Tidsramme: Baseline
|
The width of the keratinized gingiva was measured via a periodontal probe from the mucogingival margin to the gingival margin.
|
Baseline
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: TUGBA SAHIN, Abant Izzet Baysal University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
11. juni 2024
Primær færdiggørelse (Faktiske)
2. marts 2026
Studieafslutning (Faktiske)
3. marts 2026
Datoer for studieregistrering
Først indsendt
27. april 2026
Først indsendt, der opfyldte QC-kriterier
27. april 2026
Først opslået (Faktiske)
4. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
4. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
27. april 2026
Sidst verificeret
1. april 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- BAIBU-DH-TS-07
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
UBESLUTET
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .